Litigation Details for OncoImmune, Inc. v. Ohio State Innovation Foundation, Inc. (D. Maryland 2017)
✉ Email this page to a colleague
OncoImmune, Inc. v. Ohio State Innovation Foundation, Inc. (D. Maryland 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-09-13 |
| Court | District Court, D. Maryland | Date Terminated | 2018-08-10 |
| Cause | 35:1 Establishment of PTO | Assigned To | Paula Xinis |
| Jury Demand | Plaintiff | Referred To | |
| Parties | ONCOIMMUNE, INC. | ||
| Patents | 6,875,904 | ||
| Attorneys | Pamela Anne Bresnahan | ||
| Firms | Dickinson Wright Pllc | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in OncoImmune, Inc. v. Ohio State Innovation Foundation, Inc.
The biologic drug covered by the patent cited in this case is ⤷ Sign Up .
Details for OncoImmune, Inc. v. Ohio State Innovation Foundation, Inc. (D. Maryland 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-09-15 | 7 | The PATENT RIGHTS are said to include the claims of U.S. Patent Nos. 6,875,904, 7,161,… Amendment updates the PATENT RIGHTS by listing the status of the 21 patents and applications identified…contributing to infringement of the PATENT RIGHTS. To the extent that the PATENT RIGHTS have expired or been…under the PATENT RIGHTS and, as such, OncoImmune is not contributing to infringement of the PATENT … and does not constitute an infringement of any patent rights OSIF may have in the MAB Technology; | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
